Endometrial cancer is the most commonly diagnosed gynecologic malignancy in the United
States. Endometrioid endometrial carcinomas constitute approximately 85% of newly …

Endometrial cancer (EC) is one of the most common gynecologic cancers and its incidence
is rising globally. Although advanced EC has a poor prognosis; diagnosing EC at an earlier …

Importance Uterine cancer incidence has been increasing, particularly rates of aggressive,
nonendometrioid subtypes, which are disproportionately higher among non-Hispanic Black …

PURPOSE Uterine corpus cancer incidence rates have been projected to increase, a
prediction often attributed to the obesity epidemic. However, correct estimation of these rates …

Endometrial cancer (EC) is a prevalent uterine cancer that remains a major contributor to
cancer-associated morbidity and mortality. EC diagnosed at advanced stages shows a poor …

Endometrial cancer is the most common malignancy of the female genital tract and its
incidence is rising in parallel with the mounting prevalence of obesity. Early diagnosis has …

Simple Summary Endometrial cancer (EC) represents 90% of uterine cancer and to date its
standard clinical approach is still surgery and/or chemo-and radiotherapy. This mini-review …

Endometrial cancer (EC) is the most common gynaecological malignancy, and its incidence
is rising alongside the growing prevalence of obesity. Effective risk-reducing interventions …

Endometrial cancer is the leading gynaecological malignancy in the western world and its
incidence is rising in tandem with the global epidemic of obesity. Early diagnosis is key to …

Perfluorooctanoic acid (PFOA) alternatives such as hexafluoropropylene oxide homologs
(HFPOs) cause concern due to increased occurrence in the environment as well as potential …